Roche Partners with Ionis for RNA-Targeting Neurology Programmes
By Lucy Haggerty
Pharma Deals Review: Vol 2023 Issue 10 (Table of Contents)
Published: 10 Oct-2023
DOI: 10.3833/pdr.v2023.i10.2807 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
In an attempt to expand its neurology pipeline, Roche has signed an agreement with long-standing partner, Ionis Pharmaceuticals, for two novel RNA-targeted programmes for Alzheimer’s disease and Huntington’s disease...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS